tiprankstipranks
Trending News
More News >
Biomea Fusion’s Strategic Shift: A Year of Transformation
PremiumCompany AnnouncementsBiomea Fusion’s Strategic Shift: A Year of Transformation
2M ago
Biomea Fusion reports Q4 EPS (81c), consensus (93c)
Premium
The Fly
Biomea Fusion reports Q4 EPS (81c), consensus (93c)
2M ago
Buy Rating for Biomea Fusion’s Icovamenib: A Promising Breakthrough in Diabetes Treatment
Premium
Ratings
Buy Rating for Biomea Fusion’s Icovamenib: A Promising Breakthrough in Diabetes Treatment
2M ago
Biomea Fusion announces presentation of icovamenib preclinical, clinical data
PremiumThe FlyBiomea Fusion announces presentation of icovamenib preclinical, clinical data
3M ago
Biomea Fusion reports inducement grant under Nasdaq listing rule
Premium
The Fly
Biomea Fusion reports inducement grant under Nasdaq listing rule
3M ago
Is BMEA a Buy, Before Earnings?
Premium
Pre-Earnings
Is BMEA a Buy, Before Earnings?
3M ago
Biomea Fusion reports new preclinical data on icovamenib-semaglutide study
PremiumThe FlyBiomea Fusion reports new preclinical data on icovamenib-semaglutide study
5M ago
Biomea Fusion Advances Diabetes Treatment with Positive Study Results
Premium
Company Announcements
Biomea Fusion Advances Diabetes Treatment with Positive Study Results
6M ago
Biomea’s icovamenib meets HbA1c standards in T2D, says H.C. Wainwright
Premium
The Fly
Biomea’s icovamenib meets HbA1c standards in T2D, says H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100